Overview

Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Status:
COMPLETED
Trial end date:
2025-02-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, drug levels, food effects and relative bioavailability of BMS-986365 in healthy male participants.
Phase:
PHASE1
Details
Lead Sponsor:
Celgene
Treatments:
Rabeprazole